Vanguard Group Inc. Purchases 263,828 Shares of Intuitive Surgical, Inc. $ISRG

Vanguard Group Inc. grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 33,599,661 shares of the medical equipment provider’s stock after acquiring an additional 263,828 shares during the quarter. Vanguard Group Inc. owned 9.37% of Intuitive Surgical worth $15,026,776,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Tobam increased its position in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares in the last quarter. Kilter Group LLC bought a new stake in Intuitive Surgical in the 2nd quarter worth approximately $27,000. Princeton Global Asset Management LLC bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at $30,000. Greykasell Wealth Strategies Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth $27,000. Finally, Riggs Asset Managment Co. Inc. increased its holdings in Intuitive Surgical by 84.2% during the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after buying an additional 32 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In other news, SVP Mark Brosius sold 464 shares of Intuitive Surgical stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $548.49, for a total transaction of $254,499.36. Following the sale, the senior vice president owned 131 shares of the company’s stock, valued at approximately $71,852.19. The trade was a 77.98% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $531.52, for a total value of $1,488,256.00. Following the completion of the transaction, the director owned 15,720 shares of the company’s stock, valued at approximately $8,355,494.40. This trade represents a 15.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 56,189 shares of company stock worth $30,785,441. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on ISRG. TD Cowen raised shares of Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. Truist Financial increased their price objective on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. Daiwa Securities Group lifted their target price on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday, October 24th. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, January 21st. Finally, Royal Bank Of Canada raised their price target on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, December 17th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $617.23.

Intuitive Surgical Stock Up 1.5%

Intuitive Surgical stock opened at $485.84 on Monday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $609.08. The firm has a market cap of $172.54 billion, a price-to-earnings ratio of 61.58, a price-to-earnings-growth ratio of 3.76 and a beta of 1.65. The business’s 50-day moving average price is $541.62 and its 200 day moving average price is $510.40.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the prior year, the firm posted $2.21 EPS. Intuitive Surgical’s quarterly revenue was up 18.8% compared to the same quarter last year. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.